Last updated: December 2, 2022
Sponsor: Lithuanian University of Health Sciences
Overall Status: Active - Recruiting
Phase
N/A
Condition
Stroke
Blood Clots
Cerebral Ischemia
Treatment
N/AClinical Study ID
NCT05646134
rTMS_1
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Ischemic stroke of the middle cerebral artery, confirmed by instrumental tests (CT,MRI).
- Acute hemiplegia/hemiparesis, hand motor deficit, muscle strength ≤ 4 points (asassessed by the Lovett scale).
- Time after the stroke before inclusion in the study is no more than 1 month.
- No severe deficit in cognitive functions.
Exclusion
Exclusion Criteria:
- Patients with implanted ferromagnetic or other metal devices sensitive to a magneticfield in the head or neck area; cochlear implants; implanted neurostimulators,pacemakers, or drug delivery pumps.
- Complete aphasia or severe cognitive impairment.
- Taking tricyclic antidepressants, neuroleptics, or benzodiazepines.
- Previous skull fractures or other head injuries with loss of consciousness.
- History of epilepsy or seizures.
- Spasticity of the upper limb (Ashworth scale >2 b.).
- Pregnancy
Study Design
Total Participants: 150
Study Start date:
June 01, 2021
Estimated Completion Date:
June 01, 2026
Study Description
Connect with a study center
Lithuanian University of Health Sciences
Kaunas, 44307
LithuaniaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.